Novant Health, an integrated health system serving pa­tients in North Carolina, South Carolina, and Virginia, includes 14 hospitals with 2,700 total beds, more than 450 outpatient lo­cations, and 1,100 physicians. In 2012, Novant had more than 3.7 million physician visits and 122,000 hospital admissions. A member of the Voluntary Hospital Association (VHA), Novant participated in a VHA research project that involved tracking and analyzing adverse drug events.

“The program has significantly reduced overall readmissions and those related to adverse drug events and has generated high levels of patient satisfaction.”

Results showed that many recently discharged Novant patients – particularly those on certain high-risk medications such as anticoagulants (blood thinners) and digoxin (used to treat congestive heart failure and atri­al fibrillation) – ended up being readmitted due to an adverse drug event triggered by a lack of patient understanding about his or her medication regimen. To address this problem, Novant leaders decided to develop an initiative focused on reducing ad­verse drug events and associated admissions and readmissions.


TO READ THE FULL ARTICLE…

This article is premium content and requires a subscription. If you have a subscription, then please here. If you do not have a subscription, you may purchase one below.

Best Offer: 2-Year Premium

$144.97/Every 2 Years

Get 2-Year Premium
  • 12 bimonthly print issues (accessible in PDF, Nook, Kindle, Apple Library, or digital formats) to The Remington Report
  • Full access to the remingtonreport.com
  • Access to back issues of The Remington Report
  • Download access to the articles archives
  • MarketScan reports
  • Latest news from across the continuum
  • Exclusive premium subscription articles and case studies
  • FutureFocus e-newsletter
  • TrendLens e-newsletter

1-Year Classic

$74.97/Every 1 Year

Get 1-Year Classic
  • 6 bimonthly print issues (accessible in PDF, Nook, Kindle, Apple Library, or digital formats) to The Remington Report
  • Full access to remingtonreport.com.
  • Access to back issues of the Remington Report
  • Download access to the articles archives
  • MarketScan reports
  • Latest news from across the continuum
  • Exclusive premium subscription articles and case studies
  • FutureFocus e-newsletter
  • TrendLens e-newsletter